226
|
Billingsley S, Sun A, McKinnon S, Pond G, Tsang R, Wells W, Hodgson D, Gospodarowicz M, Medlam G. A Prospective Study to Evaluate the Need for an Immobilization Device for Treating Modified Mantle Fields in Lymphoma Patients. Int J Radiat Oncol Biol Phys 2005. [DOI: 10.1016/j.ijrobp.2005.07.721] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
227
|
Bezjak A, Soyfer V, Yi Q, Sun A, Kane G, Waldron J, Cho J, Wells W, Payne D. Radiation Pneumonitis in Lung Cancer Patients - The Neglected Patient-Related Variables. Int J Radiat Oncol Biol Phys 2005. [DOI: 10.1016/j.ijrobp.2005.07.391] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
228
|
Sun A, Billingsley S, McKinnon S, Pond G, Tsang R, Wells W, Hodqson D, Gospodarowicz M, Medlam G. 73 A prospective study to evaluate the need for an immobilization device for treating modified mantle fields in lymphoma patients. Radiother Oncol 2005. [DOI: 10.1016/s0167-8140(05)80234-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
229
|
Sun A, Bezjak A, Payne D, Kane G, Waldron J, Cho J, Shepherd F, Keshavjee S, Gore E. 145 How to improve accrual to an important prospective randomized study: Prophylactic Cranial Irradiation (PCI) in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) - RTOG 0214. Radiother Oncol 2005. [DOI: 10.1016/s0167-8140(05)80306-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
230
|
Sun A, Massong C, Yi QL, Bezjak A, Payne D, Kane G, Waldron J, Cho J, Shepherd F, Nicolsong M. 146 An audit of Prophylactic Cranial Irradiation (PCI) in limited disease small cell lung cancer: Do we practice what we preach? Radiother Oncol 2005. [DOI: 10.1016/s0167-8140(05)80307-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
231
|
Koh ES, Tran T, Heydarian M, Tsang R, Pintilie M, Gospodarowicz M, Sun A, Wells W, Paul N, Hodgson D. 74 Transition from mantle RT to low-dose involved-field RT: Implications for second cancer risk among Hodgkin's lymphoma survivors. Radiother Oncol 2005. [DOI: 10.1016/s0167-8140(05)80235-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
232
|
Koh ES, Sun A, Tran T, Tsang R, Wells W, Hodgson D, Gosdodarowicz M, Heaton R, Pintilie M. 75 Clinical dose-volume histogram analysis in predicting radiation-pneumonitis in Hodgkin's disease. Radiother Oncol 2005. [DOI: 10.1016/s0167-8140(05)80236-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
233
|
Lam T, Bezjak A, Leung S, P'ng K, Mosseri A, Bissonnette JP, Sun A, Payne D, Kane G, Cho J, Waldron J. 105 Technique of hemithoracic radiotherapy after extrapleural pneumonectomy for malignant pleural mesothelioma. Radiother Oncol 2005. [DOI: 10.1016/s0167-8140(05)80266-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
234
|
Bissonnette JP, Purdie T, Sharpe M, Cho J, Kane G, Waldron J, Sun A, Payne D, Bezjak A. 50 Image-Guided Stereotactic Lung Radiation Therapy. Radiother Oncol 2005. [DOI: 10.1016/s0167-8140(05)80211-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
235
|
Sturdza A, Bezjak A, Hodgson D, Payne D, Kane G, Sun A, Waldron J, Cho J, Keshavjee S, Shepherd F. 195 Retrospective review of delays in diagnostic work-up and treatment decision. Radiother Oncol 2005. [DOI: 10.1016/s0167-8140(05)80356-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
236
|
Bezjak A, Cho Y, Abbas A, Shubbar S, Norrlinger B, Sun A, Kane G, Waldron J, Payne D. O-149 4D Radiotherapy for lung cancer: Imaging, treatment planning,and delivery. Lung Cancer 2005. [DOI: 10.1016/s0169-5002(05)80283-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
237
|
Bezjak A, Soyfer V, Yi Q, Sun A, Kane G, Waldron J, Cho J, Wells W, Payne D. P-808 Concurrent medications as potential modifiers of radiation pneumonitis in lung cancer patients. Lung Cancer 2005. [DOI: 10.1016/s0169-5002(05)81301-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
238
|
Masson C, Sun A, Yi Q, Bezjak A, Payne D, Kane G, Waldron J, Cho J, Shepherd F, Nicolson M. P-785 An audit of pophylactic cranial irradiation (PCI) in limited disease small cell lung cancer: Do we practice what we preach? Lung Cancer 2005. [DOI: 10.1016/s0169-5002(05)81278-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
239
|
Sun A, Wang JT, Chia JS, Chiang CP. Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of oral lichen planus. Br J Dermatol 2005; 152:1187-92. [PMID: 15948980 DOI: 10.1111/j.1365-2133.2005.06497.x] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
BACKGROUND Oral lichen planus (OLP) is a T-cell-mediated inflammatory disease. Interleukin (IL)-8 is a pro-inflammatory cytokine of host response to injury and inflammation. OBJECTIVES To investigate whether serum IL-8 level was a more sensitive marker than serum IL-6 level in monitoring the disease activity of OLP and to assess whether IL-8 was a useful serum marker in evaluating the therapeutic effects of levamisole on OLP patients. METHODS In this study, we used a solid phase, two-site sequential chemiluminescent immunometric assay to determine the baseline serum levels of IL-6 and IL-8 in 158 patients with OLP, nine patients with traumatic ulcers (TU) and 54 normal control subjects. Some OLP patients with the serum IL-6 or IL-8 levels higher than the upper limit of normal serum concentration were treated with levamisole for 0.5-6.0 months and their serum IL-6 and IL-8 levels were measured after treatment. RESULTS We found that 28% (44 of 158) OLP, 28% (40 of 142) erosive OLP (EOLP), and 25% (four of 16) nonerosive OLP (NEOLP) patients had a serum IL-6 level greater than the upper normal limit of 4.7 pg mL(-1). In contrast, 63% (99 of 158) OLP, 63% (90 of 142) EOLP and 56% (nine of 16) NEOLP patients had a serum IL-8 level greater than the upper normal limit of 8.7 pg mL(-1). In some OLP patients with the serum IL-6 or IL-8 levels higher than the upper limit of normal serum concentration, treatment with levamisole for a period of 0.5-6.0 months could significantly reduce the mean serum IL-6 level from 14.3 +/- 1.9 pg mL(-1) to 3.2 +/- 0.6 pg mL(-1) (P < 0.001) and could significantly reduce the mean serum IL-8 level from 95.8 +/- 17.1 pg mL(-1) to 14.8 +/- 5.8 pg mL(-1) (P < 0.001). CONCLUSIONS Because measurement of the serum IL-8 level can detect more OLP patients with an abnormal serum level than measurement of the serum IL-6 level (63% vs. 28%), we conclude that serum IL-8 level is a more sensitive marker than serum IL-6 level in monitoring the disease activity of OLP. Levamisole can modulate both the serum IL-6 and IL-8 levels in OLP patients. IL-8, like IL-6, is also a useful serum marker in evaluating the therapeutic effects of levamisole on OLP patients.
Collapse
|
240
|
Hirose M, Sun A, Okubo T, Noriki S, Imamura Y, Fukuda M. Detection of non-papillary, non-invasive transitional cell G1 carcinoma as revealed by increased DNA instability and other cancer markers. Eur J Histochem 2005; 49:199-209. [PMID: 15967748] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/03/2023] Open
Abstract
The method to reveal DNA-instability as demonstrated by immunohistochemical staining with anti-cytidine antibody after acid hydrolysis (DNA-instability test) was used as a marker of malignancy. The test was applied to paraffin-embedded sections taken from 15 urinary bladders, renal pelvic cavities, and ureters bearing multiple carcinoma in situ (CIS) and totally 31 papillary urothelial cancers. The serial sections of the same tissues were also subjected to immunohistochemical staining for PCNA, p53, DFF45, and VEGF. The DNA-instability test was positive in 100% cancer lesions irrespective of the grades, and apparently normal urothelium, and hyperplastic and dysplastic urothelial lesions also showed the areas with clones positively stained with DNA-instability testing, and the percent numbers of positive areas in them were 28.3%, 37.7%, and 61.5%, respectively. These clones, which were present in apparently normal urothelium and in hyperplastic and dysplastic urothelial lesions, showed higher percent values of PCNA-positive-cells, in comparison to the values estimated in the areas with negatively stained DNA-instability testing, and the former values were statistically not different from those in carcinoma lesions. Furthermore, the percent numbers of areas positive for p53, DFF45, and VEGF, with positive DNA-instability testing were also much higher than those with negative DNA-instability testing in apparently normal urothelium, and hyperplastic and dysplastic urothelial lesions, and the former values were again comparable to those in cancer lesions with no statistical differences. These clones were regarded as already being malignant and should be the direct precursors of progressed cancer lesions. They will make progression through two different pathways, one to papillary non-invasive G1 cancers by neovascularization induced by paracrine secretion of VEGF, and another to flat CIS G2 without secretion of VEGF; thus the clones should be regarded as non-papillary, non-invasive Gl TCC, or CIS G1. It should be always taken into account that the probability for apparently normal urothelium, and hyperplastic and dysplastic urothelial lesions to contain cancer clones, will be high already, especially in tumor-bearing bladders.
Collapse
|
241
|
Payne DB, Sun A, Butler JC, Singh SP, Hollingshead SK, Briles DE. PspA family typing and PCR-based DNA fingerprinting with BOX A1R primer of pneumococci from the blood of patients in the USA with and without sickle cell disease. Epidemiol Infect 2005; 133:173-8. [PMID: 15724724 PMCID: PMC2870235 DOI: 10.1017/s0950268804003085] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
Disease and mortality rates for Streptococcus pneumoniae infections are much higher in patients with sickle cell disease (SCD) than in age-matched patients without SCD. Pneumococcal surface protein A (PspA) has been proposed as a component in human vaccines against S. pneumoniae to provide greater breadth of coverage than can be obtained with the 7-valent conjugate vaccine. The cross-reactivity of PspA is associated with the 'PspA family' structure. In this study we examined strains of S. pneumoniae from patients with and without SCD to determine whether the strains infecting the hypersusceptible population of SCD patients were limited to the same two PspA families already known to comprise over 95% of strains infecting non-SCD patients. Each strain was also evaluated according to the presence or absence of specific PCR fragments based on repetitive BOX elements to screen for possible SCD-associated clonal structure. Strains from SCD and non-SCD patients were similarly dispersed among the most common BOX PCR groups and strains from both groups expressed a similar distribution of PspA variants. Thus, a PspA vaccine designed for the population at large should also be appropriate for patients with SCD.
Collapse
|
242
|
Zheng Y, Sun A, Han ZC. Stem cell factor improves SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model. Bone Marrow Transplant 2004; 35:137-42. [PMID: 15543197 DOI: 10.1038/sj.bmt.1704751] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Poor in vivo homing capacity of hematopoietic stem/progenitor cells (HS/PCs) from umbilical cord blood (UCB) can be reversed by short-term ex vivo manipulation with recombinant human stem cell factor (rHuSCF). This study was designed to evaluate the effect of ex vivo manipulation of UCB-derived HS/PCs with rHuSCF on human cell engraftment rates in xenotransplanted NOD/SCID mouse model. The human cell engraftment rates in xenotransplanted primary and secondary NOD/SCID mice were characterized using four-color flow cytometric analysis and progenitor assay. Grafts of rHuSCF-treated UCB CD34(+) cells resulted in significantly higher levels of human cell engraftment than that of nontreated ones in both xenotransplanted primary and secondary NOD/SCID recipients. Fresh UCB CD34(+) cells did not express either of the matrix metalloproteinase (MMP) family members MMP-2 or MMP-9. rHuSCF-treated UCB CD34(+) cells expressed significant levels of MMP-2 and MMP-9. Pretreatment of UCB CD34(+) cells with the specific MMP inhibitor completely blocked human cell engraftment in xenotransplanted NOD/SCID recipients. Our results indicate that ex vivo manipulation of human HS/PCs with rHuSCF might provide an optimal approach to develop more effective stem cell-based therapies in situations where engraftment is delayed due to limiting HS/PCs number, for example, UCB transplantation.
Collapse
|
243
|
Yan L, Ge H, Li H, Lieber SC, Natividad F, Resuello RRG, Kim SJ, Akeju S, Sun A, Loo K, Peppas AP, Rossi F, Lewandowski ED, Thomas AP, Vatner SF, Vatner DE. Gender-specific proteomic alterations in glycolytic and mitochondrial pathways in aging monkey hearts. J Mol Cell Cardiol 2004; 37:921-9. [PMID: 15522269 DOI: 10.1016/j.yjmcc.2004.06.012] [Citation(s) in RCA: 72] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/30/2004] [Revised: 06/09/2004] [Accepted: 06/15/2004] [Indexed: 10/26/2022]
Abstract
We utilized proteomic techniques in a primate model (Macaca fascicularis) of aging to determine potential mechanisms to explain gender differences in protection of the aging heart. The majority of prior work in this field utilized rodent models, and importantly no prior study utilized a proteomic approach in the aging heart. We studied changes in proteins in seven monkeys in each group (young and old males and females (YMs, OMs, YFs, and OFs, respectively)), and used two-dimensional gel electrophoresis in combination with mass spectrometry in five monkeys in each group. We found decreases (P < 0.05) in the expression of key enzymes in glycolysis (e.g. pyruvate kinase, alpha-enolase, triosephosphate isomerase), glucose oxidation (e.g. pyruvate dehydrogenase E1 beta-subunit), and the tricarboxylic acid (TCA) cycle (2-oxoglutarate dehydrogenase) in left ventricular (LV) samples from OM monkeys; these changes in glycolytic, glucose oxidation, and TCA enzymes were not observed either in YMs, YFs or OFs. We found additional gender differences in the reduced expression and function of proteins that are responsible for electron transport and oxidative phosphorylation in mitochondria only in hearts from OM monkeys, with corresponding decreased oxidation rates with NADH and ascorbate-N,N,N',N' ''-tetramethyl-p-phenylenediamine substrates. The changes in glycolytic and mitochondrial metabolic pathways in OM monkey hearts are similar to changes observed in hearts affected by diabetes or LV dysfunction, and could be involved in the mechanism for the cardiomyopathy of aging. The sparing of these changes in OF hearts could be involved in the mechanism mediating delayed cardiovascular risk in OFs.
Collapse
|
244
|
Martens C, Hodgson D, Wells W, Sun A, Bezjak A, Pintilie M, Gospodarowicz M, Tsang R. Outcome of hyperfractionated radiotherapy in chemotherapy-resistant non-Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 2004. [DOI: 10.1016/j.ijrobp.2004.07.508] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
245
|
Hodgson D, MacKenzie R, Forde N, Pintilie M, Tsang R, Wells W, Sun A, Crump M, Gospodarowicz M. Cardiac toxicity following modern treatment for hodgkins disease: Impact of combined modality treatment with doxorubicin and mediastinal radiation therapy. Int J Radiat Oncol Biol Phys 2004. [DOI: 10.1016/j.ijrobp.2004.06.169] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
246
|
Abstract
Although many studies have focused on cancer screening utilization and attitudes, no study has yet been conducted that examines community beliefs toward a cancer diagnosis and some of the beliefs about cancer and cancer patients. While certain types of cancer have been decreasing in the White population, minority populations are more likely to be diagnosed in a later stage and die of cancer. Stigmas caused by a cancer diagnosis and the disease itself may be a contributing factor in late detection and increased mortality. A telephone survey of 798 Chinese immigrants living in San Francisco was conducted. Subjects were asked several questions with established responses regarding their beliefs about cancer. One quarter of the 798 participants still believe cancer is contagious. Many also believe cancer is caused by environmental as well as personal action such as immoral behavior. A logistic regression model indicated that women who are at a low income level and have resided in the United States for an extended period of time are more likely to believe cancer is contagious. Community stigmas toward cancer and cancer survivors will prevent some Chinese immigrants from seeking early diagnosis. Multimedia education efforts that utilize print, television, and radio may provide a point of entry to reach otherwise unreachable individuals. This concerted education effort may help to dispel some of the myths regarding cancer, its treatment, and prognosis. It is hoped this would encourage a healthy dialogue about cancer, thus increasing screening and early detection among Chinese immigrants.
Collapse
|
247
|
Petersen PM, Gospodarowicz M, Tsang R, Pintilie M, Wells W, Hodgson D, Sun A, Crump M, Patterson B, Bailey D. Long-term outcome in stage I and II follicular lymphoma following treatment with involved field radiation therapy alone. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.6521] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
248
|
Sun A, Noriki S, Imamura Y, Fukuda M. Detection of cancer clones in human gastric adenoma by increased DNA-instability and other biomarkers. Eur J Histochem 2003; 47:111-22. [PMID: 12777206 DOI: 10.4081/815] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
An immunohistochemical differential staining of cancerous cells with anti-cytidine antibody after denaturation of nuclear DNA by acid hydrolysis with 2N HCl at 30 degree C for 20 min (DNA-instability test) has been used as a marker of malignancy. The test was applied to bioptic tissues of human gastric polyp assessed histopathologically as foveolar hyperplastic polyp (13 cases), mild (58 cases), moderate (86 cases), and severe (20 cases) dysplasia, and adenocarcinomas (14 cases). The serial sections of the same tissues were also subjected to immunohistochemical staining for Ki67, p53, DNA-fragmentation factor (DFF45), and basic fibroblast growth factor (bFGF). The DNA-instability test was positive in 14 (100%) adenocarcinoma cases, 20 (100%) severe dysplasia cases, 52 (60.5%) moderate dysplasia cases, and 12 (20.7%) mild dysplasia cases, indicating malignancy. All foveolar hyperplastic polyps were negative to the DNA-instability testing. Furthermore, the percentage of glands positive in the DNA-instability test steadily increased in going from mild (10%), to moderate (40%), to severe (100%) dysplasia, and adenocarcinoma (100%). All other biological markers tested in the present study showed significantly higher values in the adenoma glands, being positive to DNA-instability testing, irrespective of the dysplasia grade, as compared to those in the adenoma glands that were negative to DNA-instability testing. Furthermore, the former values were comparable to those in adenocarcinoma. These results indicate that cancer cell clones are already present at the adenoma stages showing a positive DNA-instability test, enhanced proliferative activity, p53 mutation, induction of DFF45 and bFGF. These factors allow cancer cell proliferation, producing heterogeneous subclones due to DNA-instability, enhancing their survival by escaping apoptosis, and providing abundant nutrients during the early-stage progression of gastric cancer. Based on these findings, we herein propose the concept of "procancer" (as opposed to "pre-cancer") as being a unique stage during the course of carcinogenesis and cancer progression. We designate the term to cancer clones at the very early stages of malignant progression that do not show distinguishable morphological atypia but do show positive DNA-instability testing and positive staining for various biomarkers such as Ki67, p53, DFF45, and bFGF. We also define the abnormal positive staining of these biomarkers, including the DNA-instability test as "functional atypia", compared to the ordinary morphological atypia.
Collapse
|
249
|
Mirimanoff R, Sun A, Epelbaum R, Poortmans P, Verschueren T, Scandolaro L, Villa S, Balmer Majno S, Ozsahin M, Monnard V. Primary spinal epidural lymphoma: outcome and prognostic factors in patients treated with radiotherapy: a multicenter rare cancer network (RCN) study. Int J Radiat Oncol Biol Phys 2003. [DOI: 10.1016/s0360-3016(03)01141-6] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
250
|
Tsang R, Gospodarowicz M, Pintillie M, Wells W, Hodgson D, Sun A, Crump M, Patterson B. 711 Localized mucosa-associated lymphoid tissue (MALT) lymphoma treated with radiation therapy has excellent clinical outcome. EJC Suppl 2003. [DOI: 10.1016/s1359-6349(03)90742-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|